Overall rank by patents
#2,513
of 49,997 tracked assignees
USPTO PatentsView assignee record - 155 granted patents across 29 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture).
The verdict
According to USPTO PatentsView, Genomatica ranks #2,513 of 49,997 tracked US assignees by granted-patent volume, with 155 patents across 29 technology areas.
USPTO PatentsView assignee plate
Corpus R2513 · US Corporation #2,513 · 155 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL
Nearest grant-volume peer: Access Business Group International LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
A&P Technology · near
51 score
Genomatica · this assignee
51 score
Glycom A/S · near
51 score
Nuovo Pignone SRL · near
51 score
Ssab Technology AB · near
51 score
3D Lighting… · lowest
7 score
What this shows Genomatica's Innovation Score is 51.5/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Genomatica, Inc. is a focused PatentsView assignee: 29 CPC subclasses with 93.5% of grants classified under C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture). Peak complete grant year is 2020 (20 grants) versus a trough of 9 in 2024. By volume, Genomatica sits between Access Business Group International LLC and ONO Pharmaceutical Co., Ltd..
From 2019–2021 to 2022–2024, Genomatica, Inc. moved from 54 to 39 grants (0.72x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,078. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Access Business Group International LLC
155 patents
Bnsf Railway Company
155 patents
Berkshire Grey Operating Company, Inc.
155 patents
Emerson Process Management Regulator Technologies, Inc.
155 patents
Idemia Identity & Security France
155 patents
Newport Fab, LLC
155 patents
Oce-technologies B.V.
155 patents
ONO Pharmaceutical Co., Ltd.
155 patents
Genomatica, Inc.
155 patents
What this shows Genomatica holds 155 patents at rank #2,513, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,513 in granted patent volume.
Other assignees with the most granted patents in Genomatica's primary technology class.
Two PlainPatent-derived peer sets for Genomatica, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (51 here).
Nearest assignees by average claims per patent (17.0 here).
Genomatica's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
51 Top 11% higher than 89% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 15 | 9.7% |
| 2016 | 10 | 6.5% |
| 2017 | 10 | 6.5% |
| 2018 | 17 | 11.0% |
| 2019 | 14 | 9.0% |
| 2020 | 20 | 12.9% |
| 2021 | 20 | 12.9% |
| 2022 | 17 | 11.0% |
| 2023 | 13 | 8.4% |
| 2024 | 9 | 5.8% |
| 2025partial year | 10 | 6.5% |
Top 15 of 29 technology areas
Overall rank by patents
#2,513
of 49,997 tracked assignees
51.5 out of 100
What to do with this data
Genomatica, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.